prima biomed ltd
(PRR:Australian Stock Exchange - SEATS)

Financial Statements for prima biomed ltd (PRR)

Currency in Millions of Australian Dollars	As of:	Jun 30 2009 Reclassified AUD	Jun 30 2010 Restated AUD	Jun 30 2011 Restated AUD	Jun 30 2012 AUD	4 Year Trend
Revenues		0.0	--	--	1.5
TOTAL REVENUES		0.0	0.0	--	1.5
GROSS PROFIT		0.0	0.0	--	1.5
Selling General & Admin Expenses, Total		1.6	5.8	5.6	7.8
R&D Expenses		0.6	5.1	9.5	14.5
Depreciation & Amortization, Total		0.0	0.1	0.1	0.2
Other Operating Expenses		0.1	0.5	--	--
OTHER OPERATING EXPENSES, TOTAL		2.4	11.5	15.2	22.5
OPERATING INCOME		-2.3	-11.5	-15.2	-21.0
Interest Expense		-0.1	-6.9	-6.4	--
Interest and Investment Income		--	0.5	1.1	2.7
Other Non-Operating Expenses, Total		--	--	--	-1.5
Gain (Loss) on Sale of Investments		-0.5	--	-0.6	--
Other Unusual Items, Total		--	--	--	-0.2
EBT, INCLUDING UNUSUAL ITEMS		-2.9	-18.0	-21.1	-19.9
Minority Interest in Earnings		0.0	0.0	0.0	--
Earnings from Continuing Operations		-2.9	-18.0	-21.1	-19.9
NET INCOME		-2.9	-18.0	-21.1	-19.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-2.9	-18.0	-21.1	-19.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-2.9	-18.0	-21.1	-19.9

Report Data Issue

To contact PRIMA BIOMED LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.